U.S. Ebola Patient Treated with Experimental Antiviral Drug

Oct 07, 2014


According to an AP article, Chimerix Inc. is providing its experimental antiviral drug, brincidofovir, to treat Thomas Eric Duncan, the Dallas patient who has Ebola. The drug was authorized by the Food and Drug Administration.

Brincidofovir is an antiviral drug being tested against common viruses, including one that infects patients undergoing bone marrow transplants. Laboratory tests suggested it may also work against Ebola, the article said.

The company said it is working with the FDA to finalize plans for an Ebola study of brincidofovir. The company has no other products on the market or in testing. Read the full AP article

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments